Off-label low-dose therapy in heart failure reduced ejection fraction: can we achieve the benefits of the four pillars?

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Mi-Na Kim

Korea University Anam Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail

Guideline-directed medical therapy presciption after acute heart failure hospitalization in Japan

Mr K. Kanaoka (Suita, JP)

Abstract Slides Video

Presentation thumbnail

New horizons in transthyretin cardiac amyloidosis therapy: A systematic review and meta-analysis of sodium-glucose cotransporter 2 inhibitors efficacy

Doctor M. Chacon Quiros (San Jose, CR)

Abstract Slides Video

Presentation thumbnail

Effects of early empagliflozin in acute decompensated HFrEF on ventricular systolic and diastolic parameters: interaction with endothelial function and arterial stiffness

Doctor O. Katsarou (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Cardiovascular effects of preferred HOMe-based EXercise training and extended adherence measures in systolic heart failure

Doctor M. Bahls (Greifswald, DE)

Abstract Slides Video

Presentation thumbnail

Innovative strategies and long-term outcomes in left ventricular assist devices therapy for advanced heart failure

Doctor N. Schaeffer (New York City, US)

Abstract Slides Video

Access the full session

Session thumbnail

Multidisciplinary approach to heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Real-world treatment patterns and uptitration in De Novo heart failure with reduced ejection fraction. insights from the comfe registry

Congress Session

Insights from recent HFrEF trials 2

Congress Session

Pharmacotherapy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources